India · Delayed Price · Currency is INR Goldline Pharmaceutical Statistics
Total Valuation
BOM:544759 has a market cap or net worth of INR 372.86 million. The enterprise value is 458.56 million.
| Market Cap | 372.86M |
| Enterprise Value | 458.56M |
Important Dates
The next estimated earnings date is Tuesday, September 8, 2026.
| Earnings Date | Sep 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:544759 has 9.60 million shares outstanding. The number of shares has increased by 15.04% in one year.
| Current Share Class | 9.60M |
| Shares Outstanding | 9.60M |
| Shares Change (YoY) | +15.04% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 68.33% |
| Owned by Institutions (%) | n/a |
| Float | 2.85M |
Valuation Ratios
The trailing PE ratio is 6.51.
| PE Ratio | 6.51 |
| Forward PE | n/a |
| PS Ratio | 1.20 |
| PB Ratio | 2.62 |
| P/TBV Ratio | 2.63 |
| P/FCF Ratio | 13.52 |
| P/OCF Ratio | 13.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.61, with an EV/FCF ratio of 16.63.
| EV / Earnings | 11.14 |
| EV / Sales | 1.47 |
| EV / EBITDA | 6.61 |
| EV / EBIT | 6.84 |
| EV / FCF | 16.63 |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.64.
| Current Ratio | 2.15 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 1.32 |
| Debt / FCF | 3.32 |
| Interest Coverage | 5.10 |
Financial Efficiency
Return on equity (ROE) is 33.47% and return on invested capital (ROIC) is 23.84%.
| Return on Equity (ROE) | 33.47% |
| Return on Assets (ROA) | 15.19% |
| Return on Invested Capital (ROIC) | 23.84% |
| Return on Capital Employed (ROCE) | 39.98% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.13 |
| Inventory Turnover | 1.72 |
Taxes
In the past 12 months, BOM:544759 has paid 12.68 million in taxes.
| Income Tax | 12.68M |
| Effective Tax Rate | 23.55% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 29.46 |
| Average Volume (20 Days) | 91,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544759 had revenue of INR 311.99 million and earned 41.17 million in profits. Earnings per share was 5.97.
| Revenue | 311.99M |
| Gross Profit | 200.09M |
| Operating Income | 67.00M |
| Pretax Income | 53.85M |
| Net Income | 41.17M |
| EBITDA | 69.41M |
| EBIT | 67.00M |
| Earnings Per Share (EPS) | 5.97 |
Balance Sheet
The company has 5.92 million in cash and 91.62 million in debt, with a net cash position of -85.69 million or -8.93 per share.
| Cash & Cash Equivalents | 5.92M |
| Total Debt | 91.62M |
| Net Cash | -85.69M |
| Net Cash Per Share | -8.93 |
| Equity (Book Value) | 142.50M |
| Book Value Per Share | 20.70 |
| Working Capital | 139.35M |
Cash Flow
In the last 12 months, operating cash flow was 28.15 million and capital expenditures -567,000, giving a free cash flow of 27.58 million.
| Operating Cash Flow | 28.15M |
| Capital Expenditures | -567,000 |
| Depreciation & Amortization | 2.41M |
| Net Borrowing | -18.73M |
| Free Cash Flow | 27.58M |
| FCF Per Share | 2.87 |
Margins
Gross margin is 64.13%, with operating and profit margins of 21.48% and 13.20%.
| Gross Margin | 64.13% |
| Operating Margin | 21.48% |
| Pretax Margin | 17.26% |
| Profit Margin | 13.20% |
| EBITDA Margin | 22.25% |
| EBIT Margin | 21.48% |
| FCF Margin | 8.84% |
Dividends & Yields
BOM:544759 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 5.27% |
| Buyback Yield | -15.04% |
| Shareholder Yield | -15.04% |
| Earnings Yield | 11.04% |
| FCF Yield | 7.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BOM:544759 has an Altman Z-Score of 2.69 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.69 |
| Piotroski F-Score | 5 |